Second, the increased DPP-4 activity was reported in T2DM when accompanied with a significant degree of insulin resistance (IR) [43], i.e., DPP-4 was recently proposed as a novel adipokine linking obesity to metabolic syndrome (MS) [45–47]. Here, DPP4 is linked to obesity disorder.